Abdul, Kadir L, Stacey M, Barrett-Jolley R. Emerging roles of the membrane potential: action beyond the action potential. Front Physiol. 2018;9.
2.Baez E, Echeverria V, Cabezas R, Ávila-Rodriguez M, Garcia-Segura LM, Barreto GE. Protection by Neuroglobin expression in brain pathologies. Front Neurol. 2016;7.
3.Beesley PW, Herrera-Molina R, Smalla K-H, Seidenbecher C. The Neuroplastin adhesion molecules: key regulators of neuronal plasticity and synaptic function. J Neurochem. 2014;131:268–83.
4.Benczik M, Gaffen SL. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol Investig. 2004;33:109–42.
5.Bhaskaran, S., Pollock, N., C Macpherson, P., Ahn, B., Piekarz, K.M., Staunton, C.A., Brown, J.L., Qaisar, R., Vasilaki, A., Richardson, A., et al. (2020). Neuron-specific deletion of CuZnSOD leads to an advanced sarcopenic phenotype in older mice. Aging Cell 19, e13225-e13225.
6.Börsch A, Ham DJ, Mittal N, Tintignac LA, Migliavacca E, Feige JN, et al. Molecular and phenotypic analysis of rodent models reveals conserved and species-specific modulators of human sarcopenia. Communications Biology. 2021;4:194.
PubMed PubMed Central Google Scholar
7.Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807.
8.Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol. 1988;404:71–82.
CAS PubMed PubMed Central Google Scholar
9.Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032–7.
10.Campbell MJ, McComas AJ, Petito F. Physiological changes in ageing muscles. J Neurol Neurosurg Psychiatry. 1973;36:174–82.
CAS PubMed PubMed Central Google Scholar
11.Chai RJ, Vukovic J, Dunlop S, Grounds MD, Shavlakadze T. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. PLoS One. 2011;6:e28090.
CAS PubMed PubMed Central Google Scholar
12.Chakkalakal JV, Jones KM, Basson MA, Brack AS. The aged niche disrupts muscle stem cell quiescence. Nature. 2012;490:355–60.
CAS PubMed PubMed Central Google Scholar
13.Chang NC, Chevalier FP, Rudnicki MA. Satellite cells in muscular dystrophy - lost in polarity. Trends Mol Med. 2016;22:479–96.
CAS PubMed PubMed Central Google Scholar
14.Chang WL, Lee DC, Leu S, Huang YM, Lu MC, Ouyang P. Molecular characterization of a novel nucleolar protein, pNO40. Biochem Biophys Res Commun. 2003;307:569–77.
15.Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, Denisenko-Nehrbass N, et al. Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction. Current biology : CB. 2002;12:217–20.
16.Chen J, Chen Y, Pu J. Leucine-rich repeat kinase 2 in Parkinson’s disease: updated from pathogenesis to potential therapeutic target. Eur Neurol. 2018;79:256–65.
17.Chen L, Chisholm AD. Axon regeneration mechanisms: insights from C. elegans. Trends Cell Biol. 2011;21:577–84.
PubMed PubMed Central Google Scholar
18.Cheng M, Nguyen MH, Fantuzzi G, Koh TJ. Endogenous interferon-gamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol. 2008;294:C1183–91.
19.Clemons, T.A., Jelks, N.T.O., Monique Vance, L., and Williams, K.S. (2020). Chapter 3 - Neuroinflammatory processes and oxidative stress. In oxidative stress and dietary antioxidants in neurological diseases, C.R. Martin, and V.R. Preedy, eds. (academic press), pp. 33-47.
20.Collinson JM, Marshall D, Gillespie CS, Brophy PJ. Transient expression of neurofascin by oligodendrocytes at the onset of myelinogenesis: implications for mechanisms of axon-glial interaction. Glia. 1998;23:11–23.
21.Corona JC, Duchen MR. PPARγ and PGC-1α as therapeutic targets in Parkinson's. Neurochem Res. 2015;40:308–16.
22.Day K, Shefer G, Shearer A, Yablonka-Reuveni Z. The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny. Dev Biol. 2010;340:330–43.
CAS PubMed PubMed Central Google Scholar
23.Deepa SS, Van Remmen H, Brooks SV, Faulkner JA, Larkin L, McArdle A, et al. Accelerated sarcopenia in cu/Zn superoxide dismutase knockout mice. Free Radic Biol Med. 2019;132:19–23.
24.Delbono O. Neural control of aging skeletal muscle. Aging Cell. 2003;2:21–9.
25.Demontis F, Piccirillo R, Goldberg AL, Perrimon N. Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models. Dis Model Mech. 2013;6:1339–52.
CAS PubMed PubMed Central Google Scholar
26.Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21:1455–63.
CAS PubMed PubMed Central Google Scholar
27.Ebert SM, Bullard SA, Basisty N, Marcotte GR, Skopec ZP, Dierdorff JM, et al. Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ. J Biol Chem. 2020;295:2787–803.
CAS PubMed PubMed Central Google Scholar
28.English AW. Cytokines, growth factors and sprouting at the neuromuscular junction. J Neurocytol. 2003;32:943–60.
29.Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993;23:2375–8.
30.Faulkner, J.A., Brooks, S.V., and Zerba, E. (1995). Muscle atrophy and weakness with aging: contraction-induced injury as an underlying mechanism. J Gerontol a biol Sci med Sci 50 spec no, 124-129.
31.Fernando R, Drescher C, Nowotny K, Grune T, Castro JP. Impaired proteostasis during skeletal muscle aging. Free Radic Biol Med. 2019;132:58–66.
32.Funk N, Munz M, Ott T, Brockmann K, Wenninger-Weinzierl A, Kühn R, et al. The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4. Sci Rep. 2019;9:4515.
PubMed PubMed Central Google Scholar
33.Gandhi PN, Chen SG, Wilson-Delfosse AL. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease. J Neurosci Res. 2009;87:1283–95.
CAS PubMed PubMed Central Google Scholar
34.Gaponova AV, Deneka AY, Beck TN, Liu H, Andrianov G, Nikonova AS, et al. Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget. 2017;8:19156–71.
35.Garcia-Reitbock P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E, et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain. 2010;133:2032–44.
PubMed PubMed Central Google Scholar
36.Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
PubMed PubMed Central Google Scholar
37.Goldspink G, Fernandes K, Williams PE, Wells DJ. Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscular disorders : NMD. 1994;4:183–91.
38.Gonzalez E, Delbono O. Age-dependent fatigue in single intact fast- and slow fibers from mouse EDL and soleus skeletal muscles. Mech Ageing Dev. 2001;122:1019–32.
39.Gupte, A.A., Bomhoff, G.L., and Geiger, P.C. (2008). Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. Journal of applied physiology (Bethesda, md : 1985) 105, 839-848.
40.Ham, D.J., Börsch, A., Chojnowska, K., Lin, S., Leuchtmann, A.B., Ham, A.S., Thürkauf, M., Delezie, J., Furrer, R., Burri, D., et al. (2021). Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle bioRxiv, 2021.2005.2028.446097.
41.Ham DJ, Börsch A, Lin S, Thürkauf M, Weihrauch M, Reinhard JR, et al. The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia. Nat Commun. 2020;11:4510.
CAS PubMed PubMed Central Google Scholar
42.Hammarlund M, Jin Y. Axon regeneration in C. elegans. Curr Opin Neurobiol. 2014;27:199–207.
43.Hilden J. Testing statistical hypotheses of equivalence. Stefan Wellek, Chapman & Hall/CRC, Boca Raton, 2003. No. of pages: xvi + 284. ISBN 1-58488-160-7. Stat Med. 2003;22:3111–2.
44.Ho PW, Ho JW, Liu H-F, So DH, Tse ZH, Chan K-H, et al. Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease. Transl Neurodegener. 2012;1:3–3.
CAS PubMed PubMed Central Google Scholar
45.Hou C, Wang Y, Liu J, Wang C, Long J. Neurodegenerative disease related proteins have negative effects on SNARE-mediated membrane fusion in pathological confirmation. Front Mol Neurosci. 2017;10:66–6.
PubMed PubMed Central Google Scholar
46.Howard EE, Pasiakos SM, Blesso CN, Fussell MA, Rodriguez NR. Divergent roles of inflammation in skeletal muscle recovery from injury. Front Physiol. 2020;11.
47.Hughes DC, Marcotte GR, Marshall AG, West DWD, Baehr LM, Wallace MA, et al. Age-related differences in Dystrophin: impact on force transfer proteins, membrane integrity, and neuromuscular junction stability. J Gerontol A Biol Sci Med Sci. 2017;72:640–8.
48.Jackson MJ, McArdle A. Age-related changes in skeletal muscle reactive oxygen species generation and adaptive responses to reactive oxygen species. J Physiol. 2011;589:2139–45.
留言 (0)